Rodrigo Petersen Saadi

Dr. Rodrigo Petersen Saadi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
ATAna Paula Tagliari
Ana Paula Tagliari
ESEduardo Keller Saadi
Eduardo Keller Saadi
MMMarcelo Miglioranza
Marcelo Miglioranza
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for patients with severe symptomatic aortic stenosis (AS) whose procedural efficacy and safety have been continuously improving. Appropriate preprocedural planning, including aortic valve annulus measurements, transcatheter heart valve choice, and possible procedural complication anticipation is mandatory to a successful procedure. The gold standard for preoperative planning is still to perform a multi-detector computed angiotomography (MDCT), which provides all the information required. Nonetheless, 3D echocardiography and magnet resonance imaging (MRI) are great alternatives for some patients. In this article, we provide an updated comprehensive review, focusing on preoperative TAVR planning and the standard steps required to do it properly.

26 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ATAna Paula Tagliari
Ana Paula Tagliari
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
EMEduardo Ferreira Medronha
Eduardo Ferreira Medronha
ESEduardo Keller Saadi
Eduardo Keller Saadi
Transcatheter aortic valve implantation (TAVI) to manage structural bioprosthetic valve deterioration has been successful in mitigating the risk of a redo cardiac surgery. However, TAVI-in-TAVI is a complex intervention, potentially associated with feared complications such as coronary artery obstruction. Coronary obstruction risk is especially high when the previously implanted prosthesis had supra-annular leaflets and/or the distance between the prosthesis and the coronary ostia is short. The BASILICA technique (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction) was developed to prevent coronary obstruction during native or valve-in-valve interventions but has now also been considered for TAVI-in-TAVI interventions. Despite its utility, the technique requires a not so widely available toolbox. Herein, we discuss the TAVI-in-TAVI BASILICA technique and how to perform it using more widely available tools, which could spread its use.

1 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ATAna Paula Tagliari
Ana Paula Tagliari
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
ESEduardo Keller Saadi
Eduardo Keller Saadi
Transcatheter aortic valve implantation (TAVI) to treat patients with severe symptomatic aortic stenosis is a well-established procedure. Even though cases series have reported TAVI use in high-risk patients with pure native aortic regurgitation, this is still considered an off-label intervention, especially when the aortic annulus dimensions are beyond the recommended by prosthesis manufacturers. Herein, we provide an updated review regarding the transcatheter treatment of pure native aortic regurgitation and illustrate this issue by presenting a clinical case of a patient with pure aortic regurgitation and a large aortic annulus who received a self-expanding non-dedicated transcatheter heart valve.

1 January 2021 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
ATAna Paula Tagliari
Ana Paula Tagliari
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
Enrico FerrariEnrico Ferrari
Enrico Ferrari
MTMaurizio Taramasso
Maurizio Taramasso
ESEduardo Keller Saadi
Eduardo Keller Saadi
With transcatheter aortic valve implantation (TAVI) technology expanding its indications for low-risk patients, the number of TAVIeligible patients will globally grow, requiring a better understanding about the second-best access choice. Regarding the potential access sites, the transfemoral retrograde route is recognized as the standard approach and first choice according to current guidelines. However, this approach is not suitable in up to 10-15% of patients, for whom an alternative non-femoral access is required. Among the alternative non-femoral routes, the transaxillary approach has received increasing recognition due to its proximity and relatively straight course from the axillary artery to the aortic annulus, which provides a more accurate device deployment. Here we discuss some particular aspects of the transaxillary access, either percutaneously performed or by cutdown dissection.

18 February 2021 in Future Cardiology
Verified
Journal Article
Closed access
ATAna Paula Tagliari
Ana Paula Tagliari
AKAdriano Nunes Kochi
Adriano Nunes Kochi
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
BMBernardo Mastella
Bernardo Mastella
ESEduardo Keller Saadi
Eduardo Keller Saadi
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
Axillary vein puncture guided by ultrasound (US-Ax) versus cephalic vein dissection in pacemaker and defibrillator implant: a multicenter randomized clinical trial is a recently published study in ... Lay abstract Recently a study evaluating two different approaches to cardiac devices implant was published. In the study, 88 patients were assigned to one of two methods for this procedure. The ope...

4 May 2022 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
RSRodrigo Petersen Saadi
Rodrigo Petersen Saadi
ATAna Paula Tagliari
Ana Paula Tagliari
CPCarisi Anne Polanczyck
Carisi Anne Polanczyck
JLJoão Carlos Ferreira Leal
João Carlos Ferreira Leal
ESEduardo Keller Saadi
Eduardo Keller Saadi
Transcatheter aortic valve replacement (TAVR) to treat degeneration of bioprosthetic heart valves (BHVs), called as valve-in-valve (ViV), is becoming a key feature since the number of BHVs requiring intervention is increasing and many patients are at high risk for a redo cardiac surgery. However, a TAVR inside a small previous cardiac valve may lead to prosthesis-patient mismatch (PPM) and not be as effective as we hoped for. An effective option to decrease the chance of PPM is to fracture the previous heart valve implanted using a high-pressure balloon. By performing a valve fracture, the inner valve ring of small BHVs can be opened up by a single fracture line, allowing subsequent implantation of a properly sized transcatheter heart valve, without increasing substantially the procedure risk. In this article, we provide a step-by-step procedure on how to safely and properly fracture a BHV and report a case of a TAVR in a degenerated rapid deployment valve.